Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03682536 |
|---|---|
| Brief Title: | Efficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell Transfusions (COMMANDS) |
| First Submitted : | September 7, 2018 |
| First Submitted that Met QC Criteria : | September 20, 2018 |
| First Posted : | September 24, 2018 |
| Last Update Submitted that Met QC Criteria : | October 6, 2021 |
| Last Update Posted : | October 7, 2021 |